Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

# Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 - Summary **What the Bill Would Do:** This bill would help fund educational programs about a rare kidney cancer called renal medullary carcinoma (RMC). Specifically, it would allow states to receive federal Medicaid funds to cover 50% of the costs for teaching people with sickle cell disease or sickle cell trait about their increased risk of developing this cancer. The federal government would essentially split the bill with states for these awareness and education efforts. **Who It Affects:** The bill primarily targets people with sickle cell disease and sickle cell trait, as they have significantly higher rates of this rare cancer compared to the general population.

States would also be affected, as they could apply for federal funding to help offset education program expenses. Healthcare providers and patients would benefit from better information about this health risk. **Current Status:** The bill (HR 124) was introduced in the 119th Congress by Representative Al Green (D-TX) but remains in committee, meaning it has not yet been voted on by the full House of Representatives. No action has been taken on it at this time.